EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 24-Jun-2026 08:15 ET (24-Jun-2026 12:15 GMT/UTC)

American Gastroenterological Association’s GI Opportunity Fund backs Amplified Sciences' work to advance pancreatic cyst care

American Gastroenterological Association
Business Announcement

Amplified Sciences, a clinical-stage diagnostics company pioneering next-generation multi-omic assays, today announced a new investment from the American Gastroenterological Association’s (AGA) GI Opportunity Fund as part of its recent Seed+ financing round.

Researchers uncover how aging cells may trigger heart attacks and strokes

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Researchers at The University of Texas MD Anderson Cancer Center have discovered a molecular pathway that drives certain stressed or aging cells to become abnormally active, causing inflammation inside blood vessel plaques. This results in disturbed blood flow and high-risk lesions that can lead to blood clots that cause heart attacks or strokes.

Journal: Circulation Research

Notch2 signaling: a key driver of breast cancer dormancy in bone marrow

Editorial Office of West China School of Stomatology, Sichuan University
Peer-Reviewed Publication

Breast cancer can remain dormant in the bone marrow for decades before reactivating, resulting in cancer relapse. A study published in Bone Research unveils the critical role of Notch2 signaling pathway in promoting this dormant state. The study explains how dormant cancer cells mimic healthy stem cells and activate stress pathways to survive in the bone marrow—paving the way for innovative targeted therapies against dormant cancer cells.

Journal: Bone Research

KAIST reveals principle behind ultra-fast DNA repair, like “finding a needle in Seoul"

The Korea Advanced Institute of Science and Technology (KAIST)
Peer-Reviewed Publication

DNA is the blueprint of the human body. However, tens of thousands of DNA lesions occur in our bodies every day. In particular, if “apurinic/apyrimidinic sites” (AP sites, damaged sites where one letter of DNA information has been erased) are not properly repaired, they can lead to cancer and aging. Finding these tiny damaged sites within the vast genome is as difficult as “finding a single needle in Seoul.” Korean researchers have uncovered the secret of how a DNA repair enzyme rapidly searches for damaged sites by sliding along DNA.

Funder: National Research Foundation of Korea, Korea Drug Development Fund, Institute for Basic Science, the Institute of Information & Communications Technology Planning & Evaluatio

A dual metabolic strike: Copper-based nano-PROTACs strengthen cuproptosis cancer therapy

Research
Peer-Reviewed Publication

What happens if cancer cells lose both their mitochondrial energy supply and their glycolytic backup system? This question is central to a new study published in Research by researchers from Northwestern Polytechnical University and collaborating institutions. The work addresses a key limitation of cuproptosis-based cancer therapy: copper-dependent mitochondrial stress can kill cancer cells, but many tumors are metabolically flexible and rely heavily on aerobic glycolysis to survive mitochondrial damage. The study proposes a way to block both routes at once.

Journal: Research
Funder: Shenzhen Science and Technology Program, National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province, Postdoctoral Research Project of Shaanxi Province, Innovation Capability Support Program of Shaanxi

New CAR T treatment opens doors for patients in need of kidney transplant

University of Pennsylvania School of Medicine
Peer-Reviewed Publication

A pioneering clinical trial has successfully enabled two patients with end-stage kidney disease to receive previously improbable kidney transplants. These individuals were considered among the most difficult in the nation to match with a compatible donor kidney due to harmful antibodies they had developed (“sensitized”). Researchers at the University of Pennsylvania (Penn) used chimeric antigen receptor (CAR) T-cell therapy, originally developed at Penn for treatment of blood cancer, to significantly reduce the level of harmful immune antibodies in these two highly sensitized patients, making kidney transplantation possible after years of waiting. The study’s findings appear today in the New England Journal of Medicine.

Journal: New England Journal of Medicine

Oral drug combination eases treatment burden for AML patients

Weill Cornell Medicine
Peer-Reviewed Publication

The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is an effective alternative to the current standard, which requires repeated hospital or office visits for intravenous treatment. In the international phase 1/phase 2 trial led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, Yale University and MD Anderson Cancer Center, patients took a regimen of two pills, decitabine-cedazuridine and venetoclax, with strong response rates and survival outcomes.

Journal: New England Journal of Medicine

UM Greenebaum Comprehensive Cancer Center is first in region to offer innovative cell therapy for synovial sarcoma

University of Maryland School of Medicine
Business Announcement

The University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) is the first in the Maryland, Delaware, Virginia, and Washington D.C. region to offer an innovative cell therapy treatment for patients with an advanced type of soft tissue cancer, known as synovial sarcoma. This single-infusion T-cell therapy, called TCR-T therapy, involves engineering a patient’s own white blood cells to recognize and attack cancer cells.

American Cancer Society warns of increase in U.S. food swamps; no substantial progress reducing food deserts for millions of people

American Cancer Society
Peer-Reviewed Publication

Imagine not having access to affordable, healthy food. For many Americans, it’s a reality. A new study by researchers at the American Cancer Society (ACS) shows that between 2003 and 2023, nearly five million people in the United States lived in food deserts, places with no grocery stores. Most of these deserts are in poor and rural areas and in places where people rely on public transit. At the same time, the number of food swamps or areas with mostly restaurants/fast-food locations increased nationwide. The findings are to be published today in the American Journal of Public Health (AJPH).

Journal: American Journal of Public Health

UCF researcher studying probiotics to fight acid reflux, esophageal cancer

UCF College of Medicine
Grant and Award Announcement

Associate Professor Dr. Claudia Andl is examining how a simple probiotic can treat the damage from acid reflux disease, a condition that affects one-fourth of Americans and increases their risk for esophageal cancer.

Funder: Florida Department of Health

19
20
21
22
23